Data Governance: An AI in Pharma Requirement

Datagovernance

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team AI is a relatively mature field (officially born during the Dartmouth Conference in 1956) [1]. The current confluence of virtually unlimited data storage space and computational power has changed many aspects of algorithm design and implementation. For example, it … Read more

Modeling RNA Virus and Vaccine Structure

Viruses

By William Whitford (DPS Group) Purpose: AI has applications throughout the value chain, and here we introduce an application in product development. AI in Modern Medicine Artificial Intelligence (AI) is one of the major techniques defining our modern era of medicine. The various machine learning algorithms employed in drug design include Supervised Learning, Unsupervised Learning, Semi-Supervised … Read more

In Their Own Words: Participants Review the AI Summit

Digital+brain

By Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group), and AIO Team Healthcare Products Collaborative (formerly Xavier Health) is committed to improving the progression of healthcare by supporting teams of representatives of academia, solution suppliers, and pharmaceutical product sponsors to discover and publish on the newest trends and technologies.  In this blog entry by … Read more

AI in Pharma Adoption, Part 5: AI Value in Complex, Unstructured and Multiparametric Data

Data+stream

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team AI is a combination of statistics, math, algorithms and software able to establish links between the complexity of reality and the emergence of specific behaviors created by the intricate relationships of the studied units. The human body is maybe … Read more

AI in Pharma Adoption, Part 4: Three Real Use Cases of AI Implementation in Pharma – NOT Science Fiction!

Businessman Pressing Button On Touch Screen Interface And Select

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team In our last blog entry, we discussed the whats and whys around artificial intelligence (AI) transforming manufacturing. This entry sheds light upon some of the hows in anonymized accounts of real-life implementations. AI can present opportunities to improve production … Read more

AI in Pharma Adoption, Part 3: AI is Transforming Manufacturing—The Hows and Whys

Engineering Smart Factory Automated Machine Ar Augmented Reality Technology Futuristic Industry Technology Robot Arm Control Future Industrial Concept

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team Artificial Intelligence (AI)-supported real-time monitoring and advanced data techniques provide many benefits in modern manufacturing operations. These include maintaining materials inventory, troubleshooting production bottlenecks, maintaining instruments in operating order, avoiding product quality excursions, understanding scrap rates, meeting promised delivery … Read more

AI in Pharma Adoption, Part 2: “Good AI Begins With Good Data”

Artificial Intelligence (ai), Machine Learning And Modern Computer Technologies Concepts. Business, Technology, Internet And Network Concept.

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team Having data of quality is the first step in the Artificial Intelligence (AI)/ Machine Learning (ML) journey to get reliable models and valuable AI/ML outputs. There are many issues regarding data quality that can affect the design of the … Read more

AI in Pharma Adoption, Part 1: Why is AI Not Broadly Adopted in the Lifescience Industries?

Ai Lab

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), and AIO Team The statistical methods and mathematical procedures used in the pharmaceutical industry are pieces of analysis that provide critical information for decision-making. Assuming mathematics are used as an instrument in manufacturing operations, it must be managed in the same way as equipment. Artificial Intelligence … Read more

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative